Fukushima, Sachiyo
Nakanishi, Nobuto
Fujioka, Kazumichi
Suga, Kenichi
Shirakawa, Taku
Osawa, Kayo
Hara, Kanako
Tsutsumi, Rie
Urushihara, Maki
Nakagawa, Ryuji
Awano, Hiroyuki
Oto, Jun
Sakaue, Hiroshi
Iijima, Kazumoto
Matsuo, Masafumi
Article History
Received: 24 February 2021
Revised: 30 June 2021
Accepted: 2 July 2021
First Online: 17 July 2021
Funding
: Titin N-Fragment Assay Kit was partly provided from Immuno-Biological Laboratories Co. Ltd. (Gunma, Japan). This study was partly supported by a crowdfunding project entitled the Muscle Atrophy Zero Project, using the platform “Otsucle” ExternalRef removed. This study was partially supported by JSPS KAKENHI Grant Number JP20K17899.
: M.M. discloses being employed by Kobe Gakuin University, which received funding from KNC Laboratories Inc., Kobe, Japan. M.M. further discloses being a scientific adviser for the Daiichi-Sankyo Co., Tokyo, Japan, and JCR Pharma Co., Ashiya, Japan. The remaining authors declare no competing interests.
: Ethics approval was obtained from the Institutional Review Board of Kobe University (#B200211) and Tokushima University (#1425). Opt-out and opt-in informed consent at the Kobe University and Tokushima University, respectively, was obtained for this study. Written informed consent was obtained from all parents for the use of their personal medical data in research.